Antibodies against insulin-like growth factor I receptor and uses thereof

Details for Australian Patent Application No. 2004256215 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Schumacher, Ralf; Parren, Paul; Mundigl, Olaf; Vriesema-Van Vugt, Martine; Rebers, Frank; Graus, Yvo; Kuenkele, Klaus-Peter; Van De Winkel, Jan; Kopetzki, Erhard

Agent Davies Collison Cave

Pub. Number AU-B-2004256215

PCT Pub. Number WO2005/005635

Priority 03015526.1 10.07.03 EP

Filing date 9 July 2004

Wipo publication date 20 January 2005

Acceptance publication date 17 July 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/005635 Priority application(s): WO2005/005635

17 July 2008 Application Accepted

  Published as AU-B-2004256215

13 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004256218-Artificial turf filament and artificial turf system

2004256210-Device and method for simultaneously identifying blood group antigens